Cargando…
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
Beyond the encouraging results and broad clinical applicability of immune checkpoint (ICP) inhibitors in cancer therapy, ICP-based immunotherapies in the context of autoimmune disease, particularly multiple sclerosis (MS), have garnered considerable attention and hold great potential for developing...
Autores principales: | Daei Sorkhabi, Amin, Komijani, Erfan, Sarkesh, Aila, Ghaderi Shadbad, Pedram, Aghebati-Maleki, Ali, Aghebati-Maleki, Leili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634124/ https://www.ncbi.nlm.nih.gov/pubmed/37946301 http://dx.doi.org/10.1186/s12964-023-01289-9 |
Ejemplares similares
-
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
por: Daei Sorkhabi, Amin, et al.
Publicado: (2023) -
Current status of skin cancers with a focus on immunology and immunotherapy
por: Khayyati Kohnehshahri, Mahsa, et al.
Publicado: (2023) -
Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma
por: Meftahpour, Vafa, et al.
Publicado: (2022) -
Co-stimulatory agonists: An insight into the immunotherapy of cancer
por: Pourakbari, Ramin, et al.
Publicado: (2021) -
Current applications and prospects of nanoparticles for antifungal drug delivery
por: Nami, Sanam, et al.
Publicado: (2021)